borderline statistical significance

Related by string. * borderlines . Borderlines . Borderline : borderline personality disorder . borderline mentally retarded . borderline insane / STATISTICAL . Statistical : reach statistical significance . Census Bureau Statistical Abstract . Nationally Recognized Statistical / signifi cance . Significance : achieved statistical significance . achieve statistical significance * *

Related by context. All words. (Click for frequent words.) 65 polyp recurrence 63 hormone receptor negative 62 beta carotene supplementation 61 transferrin saturation 61 homocysteine concentrations 61 residual confounding 60 invasive lobular 60 serum homocysteine 60 dietary folate 60 nondiabetics 60 multivariate adjustment 60 protein excretion 59 Calcium intake 59 lobular cancer 59 hydroxyvitamin D levels 59 tHcy 59 plasma homocysteine levels 59 antioxidant supplementation 58 Adjuvant chemotherapy 58 hsCRP levels 58 clinically insignificant 58 fetal malformations 58 #ng/ml 58 flavonoid intake 58 noncancer 58 CVD mortality 58 advanced adenoma 58 perimenopausal women 58 testosterone supplementation 58 regression coefficient 58 BRCA1 mutation carriers 58 shorter telomere length 58 haemorrhagic strokes 58 thyrotropin levels 58 mmol liter 58 multivariable analysis 58 selenium supplementation 58 Cochrane reviewers 58 serum BDNF 58 colorectal adenoma 58 nmol l 58 multivariable adjusted 57 elevated CRP 57 triglyceride concentrations 57 triglyceride concentration 57 MMSE score 57 acrylamide intake 57 DHEA supplementation 57 neutrophil counts 57 metabolized differently 57 attain statistical significance 57 nonsignificant difference 57 statistically significant predictor 57 confidence interval #.#-#.# 57 nonfatal MI 57 thiopurine 57 nondiabetic patients 57 folate vitamin B 57 Dietary fat 57 Heritability 57 unmeasured confounders 57 intact parathyroid hormone 57 nonfasting 57 lobular involution 57 lowering homocysteine 56 HbA 1c levels 56 nmol L. 56 invasive ductal 56 locoregional recurrence 56 orofacial clefts 56 folate concentrations 56 highest quintile 56 stone formers 56 cranial irradiation 56 familial aggregation 56 advanced adenomas 56 % CI #.#-#.# [008] 56 nonsignificant 56 TT genotype 56 #.#/#.# mmHg [001] 56 hyperplastic polyps 56 aOR 56 postmenopausal hormones 56 beta carotene supplements 56 unmeasured confounding 56 hormone receptor status 56 anti HBs 56 selenium intake 56 fructosamine 56 IV bisphosphonates 56 TNF blocker therapy 56 dietary acrylamide 56 Avandia Actos 56 liver metastasis 56 dietary calcium intake 56 parous women 56 generalisable 56 #OHD levels 56 fibrate drugs 56 eosinophil count 56 tibolone 56 arterial thromboembolic events 56 lowest tertile 56 triacylglycerol concentrations 55 HER2 expression 55 Hilakivi Clarke 55 extracolonic findings 55 subclinical hyperthyroidism 55 serum creatinine levels 55 extracolonic 55 plasma leptin 55 apolipoprotein B 55 VLDL cholesterol 55 bowel polyps 55 Wactawski Wende 55 HbA1C 55 noncardiovascular mortality 55 Subgroup analysis 55 albumin excretion rate 55 ß carotene 55 adenoma detection 55 follicular adenoma 55 initiating antiretroviral therapy 55 Soy isoflavones 55 haemorrhagic stroke 55 intima media thickness 55 histologic subtype 55 inversely associated 55 neurodevelopmental impairment 55 adenoma recurrence 55 HOMA IR 55 univariate analyzes 55 acetaminophen toxicity 55 Schaffir 55 lactate dehydrogenase 55 Winkelmayer 55 milli grams 55 thiazide diuretics 55 visceral adiposity 55 folic acid vitamin B6 55 lignan intake 55 % Confidence Interval 55 biologically plausible 55 PSA nadir 55 Ticlid 55 Genetic variation 55 latent celiac disease 55 hematopoietic cancers 55 pre eclamptic 55 statistically significant correlation 55 univariate analysis 55 vitamin D inadequacy 55 lymphomas leukemias 55 lymphatic cancers 55 MMSE scores 55 nonselective NSAIDs 55 potassium excretion 55 colorectal neoplasia 55 AChE inhibitors 55 serum parathyroid hormone 55 decompensated cirrhosis 55 periprocedural MI 55 BRCA mutation carriers 55 Plasma concentrations 55 hippocampal volume 55 serum GGT 55 chromium supplementation 55 colorectal neoplasms 55 axillary node 55 serum PSA 55 limiting generalizability 55 dietary folate intake 55 creatinine ratio 55 postoperative mortality 55 nmol 54 atorvastatin #mg 54 urinary calcium 54 serum folate concentrations 54 obstructive CAD 54 clomipramine 54 folic acid intake 54 impaired insulin secretion 54 Pischon 54 Boffetta 54 distal colon cancer 54 folic acid vitamin B# 54 extracapsular extension 54 elevated LDH 54 antiandrogens 54 p = #.# [003] 54 Multivariate analyzes 54 mmol l 54 adiponectin levels 54 euthyroid 54 Estrogen receptor positive 54 serum calcium 54 nmol liter 54 plasma homocysteine 54 Polyunsaturated fat 54 elevated ALT 54 preterm neonates 54 Subgroup analyzes 54 gestational hypertension 54 HbA1C levels 54 conjugated estrogen 54 mcg dL 54 unmeasured factors 54 NNRTI resistance 54 MDRD 54 nanograms milliliter 54 BRCA2 mutation carriers 54 Genetic predisposition 54 Shlipak 54 dose statin therapy 54 prolongs survival 54 menthol smokers 54 drank caffeinated 54 pCR 54 mammographically 54 endometrial thickness 54 vitamin D calcium 54 sitosterol 54 unsupplemented 54 metformin monotherapy 54 hippocampal volumes 54 LV dysfunction 54 overt hypothyroidism 54 serum lipid levels 54 μmol L 54 Ishak fibrosis score 54 nonfasting triglyceride levels 54 pure fructose 54 incidentalomas 54 umol L 54 lowering homocysteine levels 54 Hb A1C 54 polytherapy 54 obstructive coronary artery 54 nondepressed 54 impair fertility 54 CC genotype 54 Ascherio 54 underactive thyroids 54 G. biloba 54 ß blockers 54 serum LDL cholesterol 54 hydroxyvitamin D concentrations 54 cardiotoxic 54 gastric cardia 54 N telopeptide 54 tumor subtype 54 TMPRSS2 ERG fusion 54 isoflavone supplements 54 CYP#D# inhibitor 53 adjuvant radiotherapy 53 unmetabolized folic acid 53 SLNB 53 journal Pharmacotherapy 53 Kalantar Zadeh 53 p = .# [002] 53 baseline HbA1c 53 redox active 53 serum estradiol 53 Homocysteine levels 53 carotid IMT 53 nonvertebral fracture 53 elevated homocysteine 53 incomplete revascularization 53 CLA supplementation 53 androgen suppression 53 cancerous colon polyps 53 colorectal polyp 53 cytologic examination 53 androgen depletion 53 slow metabolizers 53 untreated celiac disease 53 serum IgE 53 magnesium intake 53 mL/min/#.# m 2 53 nmol L 53 JoAnn Manson 53 folate intakes 53 benign noncancerous 53 NNT = 53 conditional logistic regression 53 Fasting plasma glucose 53 FGFR2 gene 53 PCA3 scores 53 serum vitamin D 53 ginkgo biloba extract 53 preterm newborns 53 HbF levels 53 stratifying patients 53 mIU L 53 paricalcitol 53 fructose intolerance 53 Edward Giovannucci 53 methotrexate monotherapy 53 mmHg p = 53 #.#ng/ml 53 Calorie intake 53 recurrent venous thromboembolism 53 Cooked tomatoes 53 glomerular filtration 53 NIHSS score 53 hepatocellular carcinomas 53 BRCA2 carriers 53 sodium nitroprusside 53 lycopene intake 53 pretransplant 53 GSTM1 gene 53 HYVET 53 abdominal subcutaneous fat 53 #OHD 53 lymphocyte count 53 chlorthalidone 53 leukocyte counts 53 intelligence quotient IQ 53 echocardiographic parameters 53 neurodevelopmental outcome 53 bezafibrate 53 postoperative chemotherapy 53 plasma triglycerides 53 scintigraphic 53 CR nPR 53 bioavailable testosterone 53 Eric Rimm 53 % CI #.#-#.# [007] 53 albumin excretion 53 noncardiac 53 mIU ml 53 dietary sodium 53 μg L 53 Vitamin B9 53 gene APOE 53 urinary excretion 53 monozygotic twin 53 reboxetine 53 serotonin deficiency 53 Singh Manoux 53 CFVR 53 bivariate analyzes 53 antibody titer 53 preoperative chemotherapy 53 complete cytogenetic response 53 μg d 53 ovarian hormones 53 carotid plaque 53 rimonabant #mg 53 multivariate Cox 53 gallstone disease 53 aneuploid 53 metabolite concentrations 53 fetuin 53 visceral abdominal 53 hormone therapy estrogen 53 tertiles 53 CI #.#-#.# [001] 53 breast endometrial 53 Univariate analysis 53 CYP#D# genotype 53 serum sodium levels 53 Schunkert 53 Mofenson 53 dietary carbohydrate 53 thyrotropin 53 #q#.# deletion syndrome 53 histologically confirmed 53 probiotic supplementation 53 fasting triglyceride levels 53 dietary intakes 53 serum lipid 53 nodal metastasis 53 urinary BPA 53 folate deficiency 53 ascertainment bias 53 plasma lipid 53 milligrams deciliter 53 urate levels 53 serum uric acid 53 surrogate markers 53 multivariate analyzes 52 P ≤ 52 urine cytology 52 serum albumin 52 nonpregnant women 52 untreated hypothyroidism 52 QIDS SR 52 bronchioloalveolar carcinoma 52 serum urate levels 52 adiponectin concentrations 52 carotid bruit 52 elevated fasting glucose 52 distal colon 52 isoflavone supplement 52 Eunyoung Cho 52 statistically significant p = 52 serum ferritin 52 Tschöp 52 invasive lobular carcinoma 52 oral prednisolone 52 HbA 1c 52 absolute contraindication 52 periprocedural 52 ALT elevation 52 leukocyte count 52 drinking beetroot juice 52 antitumor effect 52 underdosed 52 paraoxonase 52 lowers homocysteine 52 glycated hemoglobin levels 52 transaminase elevations 52 serum PTH 52 NP CRNs 52 Seewaldt 52 ischemic cardiovascular 52 Leydig cell 52 palmitic acid 52 colonic polyps 52 Y BOCS 52 Radical prostatectomy 52 tertile 52 salmeterol fluticasone propionate 52 leptin deficient mice 52 LC#m# vaccine 52 Moderate drinkers 52 beta blocker therapy 52 folate intake 52 prostate carcinogenesis 52 elevated bilirubin 52 cardiac troponin T 52 mammographic breast density 52 serum triglyceride 52 APOC3 52 glycaemia 52 causally linked 52 lung nodule 52 Serum creatinine 52 mammographic density 52 mmol 52 L lysine 52 contralateral breast 52 plasma folate 52 nonfasting triglycerides 52 serum TSH 52 confounder 52 alpha defensin 52 Wassertheil Smoller 52 Breslow thickness 52 PNH patients 52 lipid lowering medications 52 creatinine levels 52 atherogenic dyslipidemia 52 comorbid illnesses 52 gm dl 52 serum CRP 52 thromboembolisms 52 K ras mutations 52 K ras mutation 52 Observational studies 52 underactive thyroid gland 52 GBA mutations 52 methodologic 52 colorectal adenomas 52 acarbose 52 #.#mmol L [002] 52 dietary glycemic index 52 LDL cholesterol HDL cholesterol 52 antioxidant vitamin supplements 52 spontaneous bacterial peritonitis 52 Bonferroni correction 52 CI -#.# 52 neurocognitive deficits 52 menstrual abnormalities 52 unexplained stillbirth 52 postmenopausal hormone replacement 52 cytologic 52 breast carcinogenesis 52 β blockers 52 gallstone formation 52 serum triglycerides 52 carotid artery narrowing 52 idraparinux 52 serum folate 52 prostate abnormalities 52 aminotransferase 52 Folic acid supplements 52 familial clustering 52 liver steatosis 52 LDL HDL 52 trans palmitoleate 52 CTEPH 52 revascularizations 52 ziprasidone 52 Hazard Ratio 52 Dietary calcium 52 β = 52 aminotransferase levels 52 causal pathway 52 heterozygotes 52 acute cholecystitis 52 HGPIN 52 Howard Sesso 52 CIN2 + 52 dietary sodium intake 52 Triglyceride levels 52 Fasting glucose 52 HER2 positive cancers 52 Gheorghiade 52 sperm morphology 52 estrogen receptor negative 52 Homocysteine 52 biopsy Gleason 52 Jon Kar Zubieta 52 psychiatric comorbidity 52 prescribed statins 52 dietary carotenoids 52 Neugut 52 plasma pharmacokinetics 52 pmol L 52 gastric carcinoma 52 artery calcification 52 ARB telmisartan 52 elevated LDL cholesterol 52 pentoxifylline 51 baseline serum creatinine 51 BLLs 51 abnormal mammograms 51 preoperative PSA 51 #.#/#.# mm Hg [003] 51 coronary artery calcification 51 coronary calcification 51 PSADT 51 coinfected patients 51 atherogenic 51 sotalol 51 #q# deletion syndrome 51 RYGB 51 Bjelakovic 51 tumor histology 51 hemoglobin A1c HbA1c 51 serum markers 51 thiazide 51 enteroviral 51 deciliter 51 elevated hsCRP 51 folate deficient 51 undergo prostate biopsy 51 GSTM1 51 lifetime abstainers 51 biopsied breast 51 lumbar spine BMD 51 serum urate 51 tryptase 51 T1c 51 surgically resectable 51 abstinent alcoholics 51 antioxidant intake 51 lowest quintile 51 pancreatic carcinogenesis 51 MS relapses 51 micromolar 51 cystatin C 51 tryptophan depletion 51 nonobese 51 SNP rs# [002] 51 Severe acne 51 morphometric vertebral fractures 51 insulin sensitizing drug 51 Insulin sensitivity 51 glycosylated hemoglobin HbA1c 51 Bresalier 51 Low birthweight 51 behavioral disinhibition 51 nonexposed 51 folates 51 C. pneumoniae 51 teratogenic 51 dysbindin 51 IQWiG 51 nonvertebral fractures 51 RfD 51 highest tertile 51 Ovary removal 51 liver transplant recipients 51 pT3 51 abnormal lipid levels 51 serum glucose 51 advanced neoplasia 51 BRCA carriers 51 #.#mmol l [002] 51 mmHg diastolic 51 thyroglobulin 51 precancerous colon growths 51 #mmHg [001] 51 fatty acid intake 51 coxib 51 prednisone prednisolone plus 51 biologic plausibility 51 nonhereditary 51 Mozaffarian 51 dose Iluvien 51 TOP2A 51 pulmonary dysfunction 51 poor metabolizers 51 salivary flow 51 pamidronate 51 hemoglobin A1c levels 51 dalteparin 51 basal cell nevus syndrome 51 plasma adiponectin 51 SOD2 gene 51 hawthorn extract 51 Calcium vitamin D 51 pancreas esophagus 51 routine neonatal circumcision 51 cervical lymph node 51 hyperinsulinemic 51 % CI #.#-#.# [003] 51 oncologic outcomes 51 dopamine D2 receptor 51 CYP#D# gene 51 oral antidiabetes 51 perioperative morbidity 51 plasma cortisol 51 CHD mortality 51 AUC0 #hr 51 Folate deficiency 51 RET PTC rearrangements 51 detectable BPA 51 stimulated insulin secretion 51 Doxil ® 51 ketogenic diets 51 nonmelanoma skin cancers 51 biochemical relapse 51 nondrinkers 51 Meyer Lindenberg 51 corneal astigmatism 51 ACCORD Lipid 51 clinicopathological features 51 B vitamin supplementation 51 statistical significance p 51 plasma lipids 51 eicosapentaenoic acid 51 inhibits platelet aggregation 51 atypical lobular hyperplasia 51 aspirin clopidogrel 51 adjuvant systemic 51 untreated OSA 51 Glutamic acid 51 antiangiogenic therapy 51 anagrelide 51 subclinical atherosclerosis 51 pg ml 51 pathologic examination 51 dietary modification 51 psychosocial functioning 51 troponin T 51 glycated hemoglobin HbA1c 51 inverse association 51 folate folic acid 51 PDE7B 51 serum cortisol 51 meta analysis pooling 51 sulphonylureas 51 monosaturated fat 51 childhood sunburns 51 precancerous polyp 51 KDOQI 51 hypertension diabetes mellitus 51 A1c levels 51 overt hepatic encephalopathy HE 51 mm Hg diastolic 51 Papillary 51 diabetic kidney 51 intracranial atherosclerosis 51 induced tumor regression 51 perinatal complications 51 CI #.#-#.# [002] 51 delayed gastric emptying 51 Suicidal ideation 51 hypovitaminosis D 51 urinary oxalate 51 hormonally sensitive 51 Serum concentrations 51 Dietary intake 51 meta analytic 51 hydroxychloroquine 51 renal toxicity 51 calcium intakes 51 c reactive protein 51 Creatinine 51 μg g 51 perinatal outcomes 51 creatine kinase 51 nanomoles per 51 prenatal exposures 51 CHADS2 51 multivariable Cox 51 interobserver reliability 51 neurodevelopmental outcomes 51 metaanalysis 51 non pharmacological interventions 51 RBP4 levels 51 tanned indoors 51 8 OHdG 51 lymphovascular invasion 51 Stolzenberg Solomon 51 ADAS Cog 51 intracranial stenosis 51 calcium Vitamin D 51 Overdiagnosis 51 APOE e4 51 metabolizing enzyme 51 β carotene 51 antiretroviral naïve 51 phytoestrogen intake 51 regression coefficients 51 esophageal acid 51 leptin deficiency 51 pharmacological therapies 51 % CI #.#-#.# [001] 51 initiating HAART 51 prolactin levels 51 biochemical abnormalities 51 darbepoetin alpha 51 penetrance 51 proximal colon 51 serum phosphate 51 Cardiorespiratory fitness 51 phyto oestrogens 51 antenatal depression 51 gross hematuria 51 Colon polyps 51 chemoresistant 51 FUS protein 51 newer atypical antipsychotics 51 Francesca Bravi 51 SHBG levels 51 eplerenone 51 PUFA intake 51 circulating IGF 50 antiphospholipid antibodies 50 PLX STROKE targeting 50 underwent surgical resection 50 mg BID dose 50 triglyceride lowering 50 ATACAND 50 intensive statin therapy 50 hamartomas 50 Hazard Ratio HR 50 VCAM 1 50 Marambaud 50 chi squared 50 mcg dl 50 ertapenem 50 odds ratios ORs 50 cirrhotic patients 50 postmenopausal hormone 50 trans palmitoleic acid 50 rho = 50 recurrent UTI 50 endometrial hyperplasia 50 serum biomarkers 50 postoperative complication 50 abnormal glucose tolerance 50 Atkins dieters cardiovascular 50 Dr. Montori 50 serum IGF 50 cardioprotective effects 50 meta analyzes 50 myocardial dysfunction 50 neurosensory 50 2D 4D ratio 50 salmeterol fluticasone 50 testicular shrinkage 50 N acetylcysteine 50 TMEM density 50 nonpsychotic 50 HBeAg 50 Telomere length 50 cardiovascular mortality 50 serum calcium levels 50 IFN alfa 50 BEXXAR Therapeutic Regimen 50 transaminase levels 50 flavonol rich 50 gestational diabetes mellitus GDM 50 arterial stiffening 50 frequent ejaculations 50 lymph node involvement 50 predisposing factor 50 oxidized LDL 50 enteroviral infection 50 PSA velocity 50 adnexal mass 50 hepatocellular carcinoma liver 50 inherited predisposition 50 APOE genotype 50 noncardiovascular 50 exposed prenatally 50 Hashimoto thyroiditis 50 genital ulcer disease 50 CYP #A# 50 poststroke depression 50 conjugated equine estrogen 50 subgroup analyzes 50 adrenal function 50 intravenous bisphosphonates 50 contraindicate 50 logistic regression analyzes 50 thiamin deficiency 50 serum magnesium 50 adjuvant therapies 50 nephrolithiasis 50 ratio ICER 50 μg liter 50 undergone radical prostatectomy 50 diastolic blood pressures 50 bronchopulmonary dysplasia 50 noncancerous prostate 50 Cognitive impairment 50 hydroxy vitamin D 50 dizygotic twins 50 primary aldosteronism 50 Multivariate analysis 50 serum cotinine levels 50 lipoprotein cholesterol 50 Elevated serum 50 patients undergoing CABG 50 Previous observational studies 50 apoC III 50 AST ALT 50 iodine intake 50 elevated triglyceride levels 50 lowers LDL 50 thromboembolic disease 50 waist circumference measurements 50 confounding variables 50 Contraceptive pill 50 wholegrain foods 50 VADT 50 imiquimod cream 50 insulin secretagogues 50 EN2 50 serum retinol 50 Djousse 50 correlational 50 Susanna Larsson 50 APOE ε4 50 neurocognitive impairments 50 ELBW infants 50 dose clopidogrel 50 XEPLION R 50 bilirubin levels 50 carotid stenosis 50 malabsorptive 50 fructose sweetened beverages 50 symptomatic intracranial hemorrhage 50 subclinical cardiovascular disease 50 cerebral microbleeds 50 URTI 50 5-FU/LV 50 lowers LDL cholesterol 50 Dahlof 50 hippocampal atrophy 50 systolic blood pressures 50 Chlamydia infection 50 tamoxifen Nolvadex ® 50 IOP lowering 50 hypoglycemic episodes 50 metachronous 50 fasting glucose levels 50 correlated inversely 50 thigh circumference 50 invasive carcinoma 50 platelet activation 50 confidence intervals CIs 50 ìg 50 lowering triglyceride levels 50 haematologic 50 STEP BD 50 urate 50 lipid lowering therapies 50 silent myocardial ischemia 50 chemoprotective 50 mmHg systolic 50 uncircumcised males 50 femoral neck BMD 50 lumbar disk herniation 50 serum concentrations 50 vitamin D supplementation 50 prognostic indicators 50 homocysteine levels 50 resected pancreatic cancer 50 biological plausibility 50 PTPN# 50 systemic hypotension 50 stimulant ADHD 50 estrone 50 estramustine 50 DHA fatty acid 50 nonischemic 50 Hgb 50 frequent ejaculation 50 carotid artery blockage 50 neuritic 50 ejection fractions 50 #q# deletion 50 strontium ranelate 50 picogram 50 chromosomal alterations 50 nonseminoma 50 HIV HCV coinfected 50 canthaxanthin 50 multifactorial disease 50 asymptomatic PAD 50 conventional angiography 50 statins cholesterol lowering 50 squamous histology 50 Reefhuis 50 Kaplan Meier analysis 50 mouthwashes containing 50 chromosomal anomalies 50 Hazard Ratio = 50 affective psychoses 50 normotensive 50 mmol L. 50 Fanconi syndrome 50 nitrite nitrate 50 inhibin B 50 postmenopausal breast cancer 50 ECD kidneys 50 atypical hyperplasia 50 lymphocytosis 50 induced oxidative stress 50 axillary node dissection 50 .5 milligrams 50 fasting plasma 50 % CI #.#-#.# [006] 50 Lp lipoprotein 50 invasive carcinomas 50 Mechanistic studies 50 statistically significant 50 artery thickening 50 histologically proven 50 methodological limitations 50 nicotine metabolite 50 methylmalonic acid 50 Unsaturated fats 50 diagnostic biomarker 50 baseline LDH 50 Vitamin D supplementation 50 pharmacological interventions 50 chlamydial infection 50 macroalbuminuria 50 nicardipine 50 chemosensitivity 50 infantile colic 50 #.#ml [002] 50 observational studies 50 Dr. Edward Giovannucci 50 Leitzmann 50 nodal metastases 50 bronchoalveolar 50 autonomic dysfunction 50 Oreopoulos 50 Viral load 50 postoperative morbidity 50 serum selenium 50 salpingo oophorectomy 50 lymphocyte counts 50 multiple logistic regression 50 unfavorable genotypes 50 FOSRENOL ® 50 hepatic enzymes 50 plasma renin 50 fibroids endometriosis 50 atherosclerotic progression 50 nonfatal stroke 50 endometrial carcinoma 50 PON1 50 symptomatic VTE 50 Boston DbTechNo Results 50 Vauthey 50 induced platelet aggregation 50 gadobutrol 49 metabolic parameters 49 phytochemicals naturally occurring 49 CIN3 49 impair cognition 49 abacavir lamivudine 49 recurrent miscarriage 49 ovariectomized rats 49 cocoa polyphenols 49 drank pomegranate juice 49 neuropsychological deficits 49 Okunieff

Back to home page